Methods:
Commercially available starting materials, reagents and dry solvents were used as supplied. Flash column chromatography was performed using Merck silica gel 60 (0.025-0.04 mm). Column chromatography was also performed on a Biotage SP1 purification system using Thomson or Biotage Flash silica cartridges. Preparative TLC was performed on Merck plates. Ion exchange chromatography was performed using acidic Isolute Flash SCX-II columns or basic Isolute Flash NH 2 columns. Preparative HPLC was conducted on an Agilent 1100 Series using a Chromolith Speed Rod column (RP18e-50-4.6), over a 15 minute gradient elution from 99:1 to 0:100 water/acetonitrile (both modified with 0.1% formic acid) at a flow rate of 50 mL/min. UV-Vis spectra were acquired at 254 nm on a Gilson 156 UVVis detector (Gilson, Middleton, USA). Collection was triggered by UV signal, and collected using a Gilson GX-281 Liquid Handler system (Gilson, Middleton, USA). Raw data was processed using Gilson Trilution Software 1 H NMR spectra were recorded on a Bruker
Avance-500. Samples were prepared as solutions in a deuterated solvent and referenced to the appropriate internal non-deuterated solvent peak. 13 C NMR spectra were recorded at 126
MHz using an internal deuterium lock. The following internal references were used: CDCl 3 ( C 77.0), CD 3 OD ( C 49.0) and DMSO-d 6 ( C 39.5); unobserved resonances for quaternary carbon atoms are denoted by "Cq not observed". LC/MS and HRMS analyses were performed on an Agilent 1200 series HPLC and diode array detector coupled to a 6210 time of flight mass spectrometer with dual multimode atmospheric pressure CI/ESI source, or coupled to a 6520 Quadrupole-Time of flight mass spectrometer with dual multimode atmospheric pressure CI/ESI source. Analytical separation was carried out at 30C on a Merck Purospher STAR column (RP-18e, 30 x 4 mm) using a flow rate of 1.5 mL/min in a 4 minute gradient elution with detection at 254 nm. The mobile phase was a mixture of methanol (solvent A) and water containing formic acid at 0.1% (solvent B). Gradient elution was as follows: 1:9 (A/B) to 9:1 (A/B) over 2.5 min, 9:1 (A/B) for 1 min, and then reversion back to 1:9 (A/B) over 0. 
piperazin-1-yl)propoxy)ethyl) carbamate (125 mg, 85% yield) as a yellow oil which was used directly in the next step.
tert-butyl(2-(3-(4-(4-(5-chloro-4-(1-oxo-2,8-diazaspiro[4.5]decan-8-yl)pyridin-3-yl)phenyl)
piperazin-1-yl)propoxy)ethyl)carbamate (125 mg, 0.199 mmol) was carried treated with DCM/TFA (6 mL, 1:1) at 0 °C and warmed to RT after 10 min. After 2 h, the solvent was evaporated and the crude product was dissolved in chloroform and loaded on an SCX-2 column (5 g). -5-(3-(piperazin-1-yl) Hz, 3H). 13 
7-(3-Chloro

